Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Maharashtra Survey Reveals High Markups on Hospital Consumables, Calls for Pricing Review

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Maharashtra Survey Reveals High Markups on Hospital Consumables, Calls for Pricing Review

Analysed 16 Sept 2026·3 sources analysed·Maharashtra, India·Business
Maharashtra Survey Reveals High Markups on Hospital Consumables, Calls for Pricing ReviewPreviousNext

A Maharashtra government survey led by Food and Drugs Administration Commissioner Tukaram Mundhe found hospital consumables like IV sets and catheters marked up by as much as 2,841% over procurement prices. Mundhe has requested the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority to review pricing rules and consider capping trade margins or including essential devices under price monitoring. The findings highlight concerns over patient protection and pricing transparency in private hospitals.

Political Bias
0%50%50%
Sentiment
59%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 50%, Right 50%). Overall sentiment is neutral (59/100). Lens Score 62/100.

Outlets measured: businessstandard, moneycontrol, mint. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 16 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 3 sources
● Left 0%● Center 50%● Right 50%

All 2 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.

Sentiment — Neutral (59/100)

Sentiment was consistent across outlets (48–70/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

mint broke this story on 15 Sept, 12:20 am. Other outlets followed.

15 Sept, 12:20 am3 sources · 26 h16 Sept, 02:15 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Jammu and Kashmir Economic Survey Projects 5.82% Growth with Sectoral Diversification
Next →
Rising Visa Fees and Restrictions Shift Skilled Tech Jobs to India Amid Global Talent Competition
  1. 1
    mint15 Sept, 12:20 am
    Mundhe flags 2,841 markup on hospital consumables, seeks NPPA review Today News
  2. 2
    moneycontrol15 Sept, 02:54 am
    IV sets bought for Rs 11.05, billed at Rs 325: Tukaram Mundhe seeks review as device markups hit 2,841 - Moneycontrol.com
  3. 3
    businessstandard16 Sept, 02:15 am
    Domestic medtech manufacturers welcome Maha FDA's call for price review

Who's involved

Institutions and figures named across source coverage.

Government
National Pharmaceutical Pricing AuthorityMinistry of Health and Family WelfareMinistry of Chemicals and FertilizersMaharashtra Food and Drugs AdministrationDepartment of PharmaceuticalsCentral Drugs Standard Control Organisation
Political
Bharatiya Janata Party

Story context

Category
Business
Location
Maharashtra, India
Sources analysed
3
Last analysed
16 Sept 2026
Key entities
TukaramProcurementIndian rupeeCatheterIntravenous therapyNational Pharmaceutical Pricing AuthorityMedical deviceFood and Drug AdministrationMaharashtraSyringeCoronary stentImplant (medicine)